Process View
The movement of a granulocyte in response to an external stimulus.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "granulocyte chemotaxis"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| S100A6 | S100 calcium binding protein A6 | 0.999 | Human | |
| CCR5 | chemokine (C-C motif) receptor 5 | 0.991 | Human | |
| S100A11 | S100 calcium binding protein A11 | 0.979 | Human | |
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.977 | Human Mouse Rat | |
| IL8 | interleukin 8 | 0.975 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.969 | Human | |
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.965 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.962 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.942 | Human | |
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.941 | ||
| S100A9 | S100 calcium binding protein A9 | 0.938 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.935 | Human | |
| S100B | S100 calcium binding protein B | 0.933 | Human | |
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.919 | Human | |
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.896 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.893 | Human Mouse Rat | |
| NCF2 | neutrophil cytosolic factor 2 | 0.888 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.887 | ||
| IL1B | interleukin 1, beta | 0.833 | Mouse Rat | |
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.810 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.808 | ||
| FLNA | filamin A, alpha | 0.789 | ||
| SYK | spleen tyrosine kinase | 0.767 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.765 | ||
| MPZL2 | myelin protein zero-like 2 | 0.761 | Human | |
| FN1 | fibronectin 1 | 0.749 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.741 | Human | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.734 | ||
| S100A8 | S100 calcium binding protein A8 | 0.721 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.719 | Human | |
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.708 | Mouse | |
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.676 | Human Mouse Rat | |
| VEGFA | vascular endothelial growth factor A | 0.658 | ||
| MPZL3 | myelin protein zero-like 3 | 0.655 | Human | |
| ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.648 | ||
| LAT | linker for activation of T cells | 0.646 | ||
| S100A14 | S100 calcium binding protein A14 | 0.643 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.606 | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.591 | Human Zebrafish | |
| S100A16 | S100 calcium binding protein A16 | 0.582 | Human | |
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.566 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.545 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.540 | Human | |
| S100A1 | S100 calcium binding protein A1 | 0.517 | Human | |
| IFNG | interferon, gamma | 0.513 | ||
| CD163 | CD163 molecule | 0.500 | ||
| EMP3 | epithelial membrane protein 3 | 0.492 | ||
| MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 0.463 | ||
| ANXA2 | annexin A2 | 0.459 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.452 | ||
| SLA | Src-like-adaptor | 0.443 | ||
| S100A4 | S100 calcium binding protein A4 | 0.443 | Human | |
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.435 | Human | |
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.434 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.424 | Human | |
| CCR7 | chemokine (C-C motif) receptor 7 | 0.418 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.408 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.402 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.389 | Human | |
| S100A12 | S100 calcium binding protein A12 | 0.369 | Human | |
| LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.362 | Human | |
| RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.349 | ||
| PLEK | pleckstrin | 0.336 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.328 | Human | |
| GRB2 | growth factor receptor-bound protein 2 | 0.315 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.305 | ||
| NRP1 | neuropilin 1 | 0.302 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.290 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.285 | ||
| CD63 | CD63 molecule | 0.246 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.239 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.236 | ||
| GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 0.234 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.226 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.223 | ||
| GAS7 | growth arrest-specific 7 | 0.220 | ||
| AREG | amphiregulin | 0.220 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.211 | Human | |
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.201 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.195 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.188 | ||
| CLEC7A | C-type lectin domain family 7, member A | 0.187 | ||
| FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | 0.184 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.181 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.180 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.176 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.173 | ||
| JAM2 | junctional adhesion molecule 2 | 0.158 | Human | |
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.154 | ||
| ST14 | suppression of tumorigenicity 14 (colon carcinoma) | 0.153 | ||
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.151 | Mouse | |
| TYROBP | TYRO protein tyrosine kinase binding protein | 0.150 | ||
| CAPG | capping protein (actin filament), gelsolin-like | 0.146 | ||
| IL10 | interleukin 10 | 0.144 | ||
| AQP9 | aquaporin 9 | 0.144 | ||
| IL2RB | interleukin 2 receptor, beta | 0.144 | ||
| RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.140 | ||
| SH3BP2 | SH3-domain binding protein 2 | 0.138 | ||
| PI3 | peptidase inhibitor 3, skin-derived | 0.136 | ||
| CD44 | CD44 molecule (Indian blood group) | 0.135 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.135 | ||
| MSN | moesin | 0.125 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.119 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.118 | Human | |
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.115 | ||
| CXCR2 | chemokine (C-X-C motif) receptor 2 | 0.114 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.112 | ||
| HCK | hemopoietic cell kinase | 0.110 | ||
| HCLS1 | hematopoietic cell-specific Lyn substrate 1 | 0.110 | ||
| PF4 | platelet factor 4 | 0.102 | ||
| TGIF1 | TGFB-induced factor homeobox 1 | 0.101 | ||
| C5AR1 | complement component 5a receptor 1 | 0.101 | Human Mouse | |
| FYN | FYN oncogene related to SRC, FGR, YES | 0.100 | ||
| PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.099 | Human | |
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.097 | Human Rat | |
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.096 | ||
| JAK1 | Janus kinase 1 | 0.095 | ||
| VAV1 | vav 1 guanine nucleotide exchange factor | 0.095 | Mouse | |
| MYO10 | myosin X | 0.094 | ||
| CD93 | CD93 molecule | 0.093 | ||
| IL18RAP | interleukin 18 receptor accessory protein | 0.093 | ||
| ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | 0.092 | ||
| CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.091 | Human | |
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.091 | Human | |
| IL2RG | interleukin 2 receptor, gamma | 0.088 | ||
| SH3BGRL3 | SH3 domain binding glutamic acid-rich protein like 3 | 0.087 | ||
| CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.087 | Human | |
| PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.082 | Human | |
| MICA | MHC class I polypeptide-related sequence A | 0.079 | ||
| CCR2 | chemokine (C-C motif) receptor 2 | 0.078 | Human | |
| CYBB | cytochrome b-245, beta polypeptide | 0.078 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.077 | Human Rat | |
| PGF | placental growth factor | 0.075 | Human | |
| TGFB1 | transforming growth factor, beta 1 | 0.074 | ||
| SLAMF7 | SLAM family member 7 | 0.074 | ||
| TMSB10 | thymosin beta 10 | 0.074 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.072 | ||
| SELE | selectin E | 0.071 | ||
| CD40LG | CD40 ligand | 0.071 | ||
| PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.069 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.068 | ||
| LST1 | leukocyte specific transcript 1 | 0.068 | ||
| PTAFR | platelet-activating factor receptor | 0.067 | ||
| TLR2 | toll-like receptor 2 | 0.066 | ||
| RNASE2 | ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) | 0.063 | ||
| LAPTM5 | lysosomal protein transmembrane 5 | 0.061 | ||
| F13A1 | coagulation factor XIII, A1 polypeptide | 0.061 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.060 | ||
| ANXA5 | annexin A5 | 0.058 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.058 | ||
| ENG | endoglin | 0.057 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.057 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.056 | ||
| TREM1 | triggering receptor expressed on myeloid cells 1 | 0.055 | ||
| IL16 | interleukin 16 (lymphocyte chemoattractant factor) | 0.055 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.055 | ||
| CD86 | CD86 molecule | 0.054 | ||
| IRF4 | interferon regulatory factor 4 | 0.053 | ||
| S100P | S100 calcium binding protein P | 0.053 | Human | |
| COL6A1 | collagen, type VI, alpha 1 | 0.052 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.052 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.051 | ||
| SELL | selectin L | 0.050 | Rat | |
| CLIC1 | chloride intracellular channel 1 | 0.050 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.049 | ||
| TNF | tumor necrosis factor | 0.049 | ||
| SH2B3 | SH2B adaptor protein 3 | 0.048 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.047 | ||
| SRGN | serglycin | 0.047 | ||
| ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.046 | ||
| JAM3 | junctional adhesion molecule 3 | 0.046 | ||
| THBS1 | thrombospondin 1 | 0.046 | Human Mouse | |
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.045 | Zebrafish | |
| FPR1 | formyl peptide receptor 1 | 0.045 | Human | |
| IL7R | interleukin 7 receptor | 0.045 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.045 | ||
| UBD | ubiquitin D | 0.045 | ||
| FKBP4 | FK506 binding protein 4, 59kDa | 0.044 | ||
| VCAN | versican | 0.044 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.043 | ||
| CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.043 | ||
| DUSP10 | dual specificity phosphatase 10 | 0.042 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.042 | ||
| ITGAM | integrin, alpha M (complement component 3 receptor 3 subunit) | 0.042 | Mouse | |
| CYBA | cytochrome b-245, alpha polypeptide | 0.042 | ||
| CH25H | cholesterol 25-hydroxylase | 0.041 | ||
| PLAU | plasminogen activator, urokinase | 0.041 | ||
| S100A10 | S100 calcium binding protein A10 | 0.040 | Human | |
| MYD88 | myeloid differentiation primary response gene (88) | 0.039 | ||
| CD33 | CD33 molecule | 0.039 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.039 | ||
| CLEC4E | C-type lectin domain family 4, member E | 0.038 | ||
| ANGPTL4 | angiopoietin-like 4 | 0.038 | ||
| RHOG | ras homolog gene family, member G (rho G) | 0.038 | Human | |
| SELP | selectin P (granule membrane protein 140kDa, antigen CD62) | 0.038 | ||
| CDC42EP3 | CDC42 effector protein (Rho GTPase binding) 3 | 0.038 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.038 | ||
| RRAS | related RAS viral (r-ras) oncogene homolog | 0.037 | ||
| RANBP9 | RAN binding protein 9 | 0.037 | ||
| GYPC | glycophorin C (Gerbich blood group) | 0.036 | ||
| EPS8 | epidermal growth factor receptor pathway substrate 8 | 0.036 | ||
| FCGR2C | Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) | 0.036 | ||
| PDZK1 | PDZ domain containing 1 | 0.036 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.035 | ||
| IDO1 | indoleamine 2,3-dioxygenase 1 | 0.035 | ||
| CALCOCO2 | calcium binding and coiled-coil domain 2 | 0.035 | ||
| FXYD3 | FXYD domain containing ion transport regulator 3 | 0.034 | ||
| LTB | lymphotoxin beta (TNF superfamily, member 3) | 0.034 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.034 | ||
| BCL2A1 | BCL2-related protein A1 | 0.034 | ||
| LGALS3 | lectin, galactoside-binding, soluble, 3 | 0.033 | ||
| INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 0.033 | ||
| FCN1 | ficolin (collagen/fibrinogen domain containing) 1 | 0.032 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.032 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.032 | ||
| GPR84 | G protein-coupled receptor 84 | 0.032 | ||
| CLC | Charcot-Leyden crystal protein | 0.031 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.031 | ||
| APLNR | apelin receptor | 0.031 | ||
| IL1A | interleukin 1, alpha | 0.030 | ||
| GPR109B | G protein-coupled receptor 109B | 0.030 | ||
| SELPLG | selectin P ligand | 0.030 | ||
| CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | 0.030 | ||
| TGFBI | transforming growth factor, beta-induced, 68kDa | 0.029 | ||
| CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 0.029 | ||
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.029 | ||
| CCL21 | chemokine (C-C motif) ligand 21 | 0.029 | ||
| MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | 0.029 | ||
| RHOC | ras homolog gene family, member C | 0.029 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.029 | ||
| FPR2 | formyl peptide receptor 2 | 0.029 | Human | |
| ADORA3 | adenosine A3 receptor | 0.028 | ||
| CA12 | carbonic anhydrase XII | 0.028 | ||
| ABI1 | abl-interactor 1 | 0.028 | ||
| MPEG1 | macrophage expressed 1 | 0.028 | ||
| RPTOR | regulatory associated protein of MTOR, complex 1 | 0.028 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.027 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.027 | ||
| SLAMF8 | SLAM family member 8 | 0.027 | ||
| IDE | insulin-degrading enzyme | 0.027 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.026 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.026 | ||
| CD247 | CD247 molecule | 0.026 | ||
| EMCN | endomucin | 0.026 | ||
| AGER | advanced glycosylation end product-specific receptor | 0.026 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.025 | ||
| AHNAK | AHNAK nucleoprotein | 0.025 | ||
| EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.025 | Human | |
| LDLR | low density lipoprotein receptor | 0.025 | ||
| ARRB2 | arrestin, beta 2 | 0.025 | ||
| VEGFC | vascular endothelial growth factor C | 0.025 | Human | |
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.025 | ||
| FPR3 | formyl peptide receptor 3 | 0.025 | Human | |
| KCNJ15 | potassium inwardly-rectifying channel, subfamily J, member 15 | 0.024 | ||
| CMKLR1 | chemokine-like receptor 1 | 0.024 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.024 | ||
| EGFR | epidermal growth factor receptor | 0.024 | ||
| FMNL1 | formin-like 1 | 0.024 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.024 | ||
| EDN1 | endothelin 1 | 0.024 | Human Rat | |
| IL2RA | interleukin 2 receptor, alpha | 0.024 | ||
| TLN1 | talin 1 | 0.024 | ||
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.024 | ||
| CXCR1 | chemokine (C-X-C motif) receptor 1 | 0.024 | Human Rat | |
| SH3RF3 | SH3 domain containing ring finger 3 | 0.024 | ||
| IL21R | interleukin 21 receptor | 0.023 | ||
| EBI3 | Epstein-Barr virus induced 3 | 0.023 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.023 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.023 | Human | |
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.023 | ||
| LCN2 | lipocalin 2 | 0.023 | ||
| NLRP3 | NLR family, pyrin domain containing 3 | 0.023 | ||
| SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.023 | ||
| PTPRE | protein tyrosine phosphatase, receptor type, E | 0.022 | ||
| CSF3R | colony stimulating factor 3 receptor (granulocyte) | 0.022 | Mouse | |
| TAGLN2 | transgelin 2 | 0.022 | ||
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.021 | ||
| SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 0.021 | ||
| OSMR | oncostatin M receptor | 0.021 | ||
| SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.021 | ||
| ITK | IL2-inducible T-cell kinase | 0.021 | ||
| ALOX5AP | arachidonate 5-lipoxygenase-activating protein | 0.021 | ||
| S100A2 | S100 calcium binding protein A2 | 0.021 | Human | |
| ADAMDEC1 | ADAM-like, decysin 1 | 0.021 | ||
| GOPC | golgi-associated PDZ and coiled-coil motif containing | 0.021 | ||
| CD69 | CD69 molecule | 0.021 | ||
| PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.021 | ||
| DARC | Duffy blood group, chemokine receptor | 0.021 | ||
| DPT | dermatopontin | 0.021 | ||
| AOAH | acyloxyacyl hydrolase (neutrophil) | 0.020 | ||
| FHL2 | four and a half LIM domains 2 | 0.020 | ||
| DCN | decorin | 0.020 | ||
| LRRC32 | leucine rich repeat containing 32 | 0.020 | ||
| FGL2 | fibrinogen-like 2 | 0.020 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.020 | ||
| IRAK4 | interleukin-1 receptor-associated kinase 4 | 0.020 | ||
| DEFB4A | defensin, beta 4A | 0.020 | ||
| CFP | complement factor properdin | 0.020 | ||
| CD97 | CD97 molecule | 0.020 | Human | |
| CD84 | CD84 molecule | 0.020 | ||
| CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.019 | ||
| FXYD5 | FXYD domain containing ion transport regulator 5 | 0.019 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.019 | ||
| CLEC5A | C-type lectin domain family 5, member A | 0.019 | ||
| PRRX1 | paired related homeobox 1 | 0.019 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.019 | ||
| IL1F5 | interleukin 1 family, member 5 (delta) | 0.019 | ||
| CXCL16 | chemokine (C-X-C motif) ligand 16 | 0.019 | ||
| CYTIP | cytohesin 1 interacting protein | 0.019 | ||
| LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.019 | ||
| LILRB3 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 | 0.019 | ||
| ENTPD1 | ectonucleoside triphosphate diphosphohydrolase 1 | 0.019 | ||
| CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.018 | Human | |
| RHOA | ras homolog gene family, member A | 0.018 | ||
| USP15 | ubiquitin specific peptidase 15 | 0.018 | ||
| INHBA | inhibin, beta A | 0.018 | ||
| CD48 | CD48 molecule | 0.018 | ||
| GZMK | granzyme K (granzyme 3; tryptase II) | 0.018 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.018 | ||
| FFAR2 | free fatty acid receptor 2 | 0.018 | ||
| ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.018 | ||
| TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | 0.018 | ||
| CD53 | CD53 molecule | 0.018 | ||
| MEST | mesoderm specific transcript homolog (mouse) | 0.018 | ||
| CCR8 | chemokine (C-C motif) receptor 8 | 0.018 | Human | |
| EFNA1 | ephrin-A1 | 0.018 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.018 | ||
| IRAK2 | interleukin-1 receptor-associated kinase 2 | 0.018 | ||
| ITGAX | integrin, alpha X (complement component 3 receptor 4 subunit) | 0.018 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.018 | ||
| CCRL2 | chemokine (C-C motif) receptor-like 2 | 0.018 | Human | |
| FCAR | Fc fragment of IgA, receptor for | 0.017 | ||
| SASH3 | SAM and SH3 domain containing 3 | 0.017 | ||
| HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.017 | ||
| GPR171 | G protein-coupled receptor 171 | 0.017 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.017 | ||
| BLNK | B-cell linker | 0.017 | ||
| CSF1R | colony stimulating factor 1 receptor | 0.017 | Zebrafish | |
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.017 | ||
| UBE2R2 | ubiquitin-conjugating enzyme E2R 2 | 0.017 | ||
| OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.017 | ||
| KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.017 | ||
| MS4A4A | membrane-spanning 4-domains, subfamily A, member 4 | 0.017 | ||
| LILRA2 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 | 0.017 | ||
| LCP1 | lymphocyte cytosolic protein 1 (L-plastin) | 0.017 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.016 | ||
| STC1 | stanniocalcin 1 | 0.016 | ||
| ACVRL1 | activin A receptor type II-like 1 | 0.016 | ||
| S100A7 | S100 calcium binding protein A7 | 0.016 | ||
| PIK3R5 | phosphoinositide-3-kinase, regulatory subunit 5 | 0.016 | ||
| CHN2 | chimerin (chimaerin) 2 | 0.016 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.016 | ||
| OASL | 2'-5'-oligoadenylate synthetase-like | 0.016 | ||
| HDAC6 | histone deacetylase 6 | 0.016 | ||
| FSTL1 | follistatin-like 1 | 0.016 | ||
| IL1F9 | interleukin 1 family, member 9 | 0.015 | ||
| PDGFC | platelet derived growth factor C | 0.015 | ||
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.015 | Mouse | |
| C2 | complement component 2 | 0.015 | ||
| IL6R | interleukin 6 receptor | 0.015 | ||
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.015 | ||
| G0S2 | G0/G1switch 2 | 0.015 | ||
| SFN | stratifin | 0.015 | ||
| CCR9 | chemokine (C-C motif) receptor 9 | 0.015 | Human | |
| CMA1 | chymase 1, mast cell | 0.015 | ||
| CLEC4M | C-type lectin domain family 4, member M | 0.015 | ||
| IGSF6 | immunoglobulin superfamily, member 6 | 0.015 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.015 | ||
| LYVE1 | lymphatic vessel endothelial hyaluronan receptor 1 | 0.015 | ||
| COL6A3 | collagen, type VI, alpha 3 | 0.015 | ||
| GNA15 | guanine nucleotide binding protein (G protein), alpha 15 (Gq class) | 0.015 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.015 | ||
| NPC2 | Niemann-Pick disease, type C2 | 0.015 | ||
| BIN2 | bridging integrator 2 | 0.015 | ||
| CAMP | cathelicidin antimicrobial peptide | 0.014 | ||
| BAIAP2 | BAI1-associated protein 2 | 0.014 | ||
| MXRA5 | matrix-remodelling associated 5 | 0.014 | ||
| SFRP2 | secreted frizzled-related protein 2 | 0.014 | ||
| TENC1 | tensin like C1 domain containing phosphatase (tensin 2) | 0.014 | ||
| SFRP4 | secreted frizzled-related protein 4 | 0.014 | ||
| SPOCK2 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 | 0.014 | ||
| AIF1 | allograft inflammatory factor 1 | 0.014 | ||
| SERPINB9 | serpin peptidase inhibitor, clade B (ovalbumin), member 9 | 0.014 | ||
| SAMSN1 | SAM domain, SH3 domain and nuclear localization signals 1 | 0.014 | ||
| FYB | FYN binding protein | 0.014 | ||
| IER3 | immediate early response 3 | 0.014 | ||
| TBX21 | T-box 21 | 0.014 | ||
| KYNU | kynureninase | 0.014 | ||
| ADRBK1 | adrenergic, beta, receptor kinase 1 | 0.014 | ||
| BST1 | bone marrow stromal cell antigen 1 | 0.014 | ||
| DOK1 | docking protein 1, 62kDa (downstream of tyrosine kinase 1) | 0.013 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.013 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.013 | ||
| DBNDD2 | dysbindin (dystrobrevin binding protein 1) domain containing 2 | 0.013 | ||
| IL12RB1 | interleukin 12 receptor, beta 1 | 0.013 | ||
| CR1 | complement component (3b/4b) receptor 1 (Knops blood group) | 0.013 | ||
| KRT1 | keratin 1 | 0.013 | ||
| MAPKAP1 | mitogen-activated protein kinase associated protein 1 | 0.013 | ||
| KLRB1 | killer cell lectin-like receptor subfamily B, member 1 | 0.013 | ||
| CYTH1 | cytohesin 1 | 0.013 | ||
| CD9 | CD9 molecule | 0.013 | ||
| CD83 | CD83 molecule | 0.013 | ||
| CDA | cytidine deaminase | 0.013 | ||
| CCL17 | chemokine (C-C motif) ligand 17 | 0.013 | Human | |
| AKT1S1 | AKT1 substrate 1 (proline-rich) | 0.013 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.013 | ||
| LAMC2 | laminin, gamma 2 | 0.013 | ||
| LILRB2 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 | 0.013 | ||
| LAMP3 | lysosomal-associated membrane protein 3 | 0.013 | ||
| CCR6 | chemokine (C-C motif) receptor 6 | 0.013 | Human | |
| IL13 | interleukin 13 | 0.013 | ||
| CCL23 | chemokine (C-C motif) ligand 23 | 0.013 | Human | |
| AEBP1 | AE binding protein 1 | 0.013 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.013 | ||
| MSC | musculin | 0.013 | ||
| FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | 0.012 | ||
| TGFA | transforming growth factor, alpha | 0.012 | ||
| IRF8 | interferon regulatory factor 8 | 0.012 | ||
| MRC1 | mannose receptor, C type 1 | 0.012 | ||
| EMR3 | egf-like module containing, mucin-like, hormone receptor-like 3 | 0.012 | Human | |
| CD14 | CD14 molecule | 0.012 | ||
| STK10 | serine/threonine kinase 10 | 0.012 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.012 | ||
| COL16A1 | collagen, type XVI, alpha 1 | 0.012 | ||
| KMO | kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) | 0.012 | ||
| GPR65 | G protein-coupled receptor 65 | 0.012 | ||
| ADAM8 | ADAM metallopeptidase domain 8 | 0.012 | ||
| ALOX5 | arachidonate 5-lipoxygenase | 0.012 | ||
| STAT4 | signal transducer and activator of transcription 4 | 0.012 | ||
| CLEC4A | C-type lectin domain family 4, member A | 0.012 | ||
| PDCD1LG2 | programmed cell death 1 ligand 2 | 0.012 | ||
| CD300A | CD300a molecule | 0.012 | ||
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.012 | ||
| IL18R1 | interleukin 18 receptor 1 | 0.012 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.012 | ||
| TFEC | transcription factor EC | 0.012 | ||
| LRRC25 | leucine rich repeat containing 25 | 0.012 | ||
| CSF3 | colony stimulating factor 3 (granulocyte) | 0.012 | ||
| CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.012 | ||
| TREM2 | triggering receptor expressed on myeloid cells 2 | 0.012 | ||
| WISP1 | WNT1 inducible signaling pathway protein 1 | 0.012 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.012 | ||
| LAG3 | lymphocyte-activation gene 3 | 0.012 | ||
| DEPTOR | DEP domain containing MTOR-interacting protein | 0.011 | ||
| CCL1 | chemokine (C-C motif) ligand 1 | 0.011 | Human | |
| HBB | hemoglobin, beta | 0.011 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.011 | ||
| SIGLEC5 | sialic acid binding Ig-like lectin 5 | 0.011 | ||
| MOBKL2B | MOB1, Mps One Binder kinase activator-like 2B (yeast) | 0.011 | ||
| IL5RA | interleukin 5 receptor, alpha | 0.011 | ||
| XCL2 | chemokine (C motif) ligand 2 | 0.011 | Human | |
| CD6 | CD6 molecule | 0.011 | ||
| ENPEP | glutamyl aminopeptidase (aminopeptidase A) | 0.011 | ||
| CTSG | cathepsin G | 0.011 | ||
| EZR | ezrin | 0.011 | ||
| LYZ | lysozyme | 0.011 | ||
| PCDH12 | protocadherin 12 | 0.011 | ||
| CD1A | CD1a molecule | 0.011 | ||
| SPP1 | secreted phosphoprotein 1 | 0.011 | ||
| IL9 | interleukin 9 | 0.011 | ||
| GRAP2 | GRB2-related adaptor protein 2 | 0.011 | ||
| NKG7 | natural killer cell group 7 sequence | 0.011 | ||
| POSTN | periostin, osteoblast specific factor | 0.011 | ||
| MYO1F | myosin IF | 0.011 | ||
| MYADM | myeloid-associated differentiation marker | 0.011 | ||
| THBS2 | thrombospondin 2 | 0.011 | Human | |
| ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) | 0.011 | ||
| CYTH4 | cytohesin 4 | 0.011 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.011 | ||
| P2RY10 | purinergic receptor P2Y, G-protein coupled, 10 | 0.011 | ||
| GSN | gelsolin | 0.011 | ||
| MFAP4 | microfibrillar-associated protein 4 | 0.011 | ||
| FERMT3 | fermitin family member 3 | 0.011 | ||
| PTK6 | PTK6 protein tyrosine kinase 6 | 0.011 | ||
| TM7SF4 | transmembrane 7 superfamily member 4 | 0.011 | ||
| PCDH17 | protocadherin 17 | 0.011 | ||
| STEAP4 | STEAP family member 4 | 0.011 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.011 | ||
| LMNA | lamin A/C | 0.011 | ||
| MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.011 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.010 | ||
| TAX1BP3 | Tax1 (human T-cell leukemia virus type I) binding protein 3 | 0.010 | ||
| LILRB5 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 | 0.010 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.010 | ||
| CD99 | CD99 molecule | 0.010 | ||
| LILRA1 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | 0.010 | ||
| AIM2 | absent in melanoma 2 | 0.010 | ||
| EMR2 | egf-like module containing, mucin-like, hormone receptor-like 2 | 0.010 | ||
| IL5 | interleukin 5 (colony-stimulating factor, eosinophil) | 0.010 | ||
| MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.010 | ||
| COL14A1 | collagen, type XIV, alpha 1 | 0.010 | ||
| MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.010 | ||
| LTF | lactotransferrin | 0.010 | ||
| GIMAP4 | GTPase, IMAP family member 4 | 0.010 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.010 | ||
| C4BPA | complement component 4 binding protein, alpha | 0.010 | ||
| PRF1 | perforin 1 (pore forming protein) | 0.010 | ||
| CST7 | cystatin F (leukocystatin) | 0.010 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.010 | ||
| ISLR | immunoglobulin superfamily containing leucine-rich repeat | 0.010 | ||
| CLEC10A | C-type lectin domain family 10, member A | 0.010 | ||
| RNASE3 | ribonuclease, RNase A family, 3 | 0.010 | ||
| PLXDC1 | plexin domain containing 1 | 0.010 | ||
| RAC3 | ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) | 0.010 | Human | |
| C1QA | complement component 1, q subcomponent, A chain | 0.010 | ||
| NRP2 | neuropilin 2 | 0.010 | ||
| ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.010 | ||
| GPSM3 | G-protein signaling modulator 3 | 0.010 |